Fosun agrees to buy KKR-backed Indian drug maker for $1.4 bln -source

HONG KONG, July 28 (Reuters) - Shanghai Fosun Pharmaceutical

Group Co Ltd has agreed to buy Gland

Pharma - which is backed by KKR & Co LP - for about $1.4

billion, a person with direct knowledge of...

Read more